| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $707K | — | +27.4% |
| Cost of Revenue | $258K | — | +11.7% |
| Gross Profit | $450K | — | +38.5% |
| R&D Expense | $86K | — | +21.1% |
| SG&A Expense | $743K | — | -15.7% |
| Operating Income | -$379K | — | +39.6% |
| Interest Expense | $91K | — | +51.7% |
| Net Income | -$464K | — | +32.7% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $434K | +29.9% | +25.4% |
| Accounts Receivable | $389K | -17.9% | +4.9% |
| Inventory | $237K | +68.1% | +229.2% |
| Current Assets | $1.2M | +12.3% | +29.1% |
| Total Assets | $1.2M | +12.1% | +28.4% |
| Current Liabilities | $3.2M | +236.8% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$250K | — | +50.3% |
| Financing Cash Flow | $350K | — | -30.0% |
| +246.8% |
| Total Liabilities | $6.7M | +9.0% | +52.3% |
| Stockholders' Equity | -$5.5M | -8.4% | -58.6% |